“…[1][2][3][4][5] Since a growing body of evidence indicates the importance of bioimaging technology, numerous kinds of bioimaging technologies, such as computed tomography (CT), single photon emission CT (SPECT), positron emission tomography (PET), X-ray imaging, radiation imaging, Raman imaging, magnetic resonance imaging (MRI), fluorescence imaging, ultrasonic imaging and photoacoustic imaging, have been developed for the diagnosis and determination of diseases in the laboratory, and preclinical and clinical trials. [4][5][6][7][8][9][10][11][12] Among them, owing to its outstanding advantages of rapid and sensitive feedback, multiple signal acquisition capability, high temporal resolution, as well as maneuverable instruments, the non-invasive fluorescence imaging method has been employed as a powerful tool for labeling and tracing specific molecules, proteins and organelles in living cells and even whole animals, and is hence capable of imaging and monitoring different diseases, [13][14][15][16][17][18][19] such as ocular diseases, different bacterial infections, cancer and lymph node (LN) metastasis. Fluorescence imaging can also be utilized to guide surgery in the treatment of disease.…”